Skip to main content

Table 1 Demographic characteristics – treated set

From: Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial

  I-C Placebo Total
Number of patients, N (%) 100 (100.0) 100 (100.0) 200 (100.0)
Sex, N (%)    
 Male 40 (40.0) 38 (38.0) 78 (39.0)
 Female 60 (60.0) 62 (62.0) 122 (61.0)
Race, N (%)    
 Asian 8 (8.0) 2 (2.0) 10 (5.0)
 Black or African American 2 (2.0) 1 (1.0) 3 (1.5)
 Hawaiian or Pacific Islander 0 1 (1.0) 1 (0.5)
 White 90 (90.0) 96 (96.0) 186 (93.0)
Age, mean (SD) [years] 20.01 (2.37) 19.93 (1.90) 19.97 (2.14)
BMI, mean (SD) [kg/m2] 23.98 (3.67) 23.66 (3.89) 23.82 (3.78)
Smoking history, N (%)    
 Never smoked 80 (80.0) 83 (83.0) 163 (81.5)
 Ex-smoker 7 (7.0) 4 (4.0) 11 (5.5)
 Current smoker 13 (13.0) 13 (13.0) 26 (13.0)
Alcohol history, N (%)    
 Does not drink 5 (5.0) 4 (4.0) 9 (4.5)
 No significant drinking 95 (95.0) 96 (96.0) 191 (95.5)
  1. BMI body mass index, SD standard deviation